Category: General

Takeda Tightens 340B Contract Pharmacy Restrictions, Biogen Exempts Nebraska From Its Restrictions Policy

April 29, 2025 Shannon Young, Associate Editor/Senior Writer Views

Japanese pharmaceutical giant Takeda recently announced changes to its 340B contract pharmacy restrictions.

A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Stakeholders React to HELP Committee Chair Cassidy’s 340B Probe Findings, Reform Recommendations

April 24, 2025 Shannon Young, Associate Editor/Senior Writer Views

340B stakeholders offered mixed responses to the findings of U.S. Sen. Bill Cassidy's (R-La.) investigation into the 340B program.

340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senate HELP Committee Chair Cassidy Calls for Federal 340B Reforms, Releases Findings of Yearslong Congressional Probe

April 24, 2025 Shannon Young, Associate Editor/Senior Writer Views

U.S. Sen. Bill Cassidy (R-La.) laid out a series of potential policies Congress could adopt to “bring much-needed reform to the 340B program” in a 195-page report, which summarized the findings of the investigation he launched in 2023—as the HELP panel’s top Republican—into how certain hospitals, health centers, chain pharmacies and drugmakers operate their 340B programs.

The leader of a key U.S. Senate Committee tasked with overseeing the 340B program called Thursday for Congress to improve [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Lobbying Remained Strong in Early 2025, Filings Show

April 24, 2025 Shannon Young, Associate Editor/Senior Writer Views

Just over 300 firms listed the 340B program in their first quarter lobbying disclosure forms that were due April 21.

While much of the focus in Washington, D.C. has been on confirmation hearings and budget matters, the 340B program continued [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health System CEOs Meet with RFK Jr. and Encourage Him to Preserve and Strengthen 340B at HHS Roundtable

April 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

The CEOs of Cincinnati’s Bon Secours Mercy Health, Cleveland-based University Hospitals, Kansas-based HaysMed and Minnesota’s Riverwood Healthcare Center met with HHS Secretary Robert F. Kennedy Jr. last week. (Photo courtesy: Kennedy's X post.)

The leaders of four health systems recently met with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Leaked HHS Budget Document Details Plans to Move 340B Program to CMS

April 18, 2025 Shannon Young, Associate Editor/Senior Writer Views

The Trump administration appears to detail its plans to move the 340B program from HRSA to CMS in a reportedly leaked internal budget document.

President Donald Trump’s (R) preliminary budget appears to call for “new authority to regulate all aspects of the 340B program,” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Tariffs on Pharmaceuticals Could Worsen Drug Shortages, Cause Disarray in 340B Prices, Advocates Say

April 17, 2025 Bella Czajkowski, National Correspondent Views

President Trump said he will implement tariffs on pharmaceuticals in the “not too distant future.” Many of the details of these potential tariffs remain unknown.

President Donald Trump’s (R) plan to place tariffs on foreign pharmaceuticals could destabilize 340B drugs’ prices unless drugmakers absorb the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GAO Report Finds HHS Must Do More to Address Drug Shortages, Doesn’t Mention 340B as a Factor

April 17, 2025 Shannon Young, Associate Editor/Senior Writer Views

A new Government Accountability Office report recommended that HHS identify and implement ways to formally coordinate activities relating to drug shortages—particularly, with a key position that oversees such actions set to end next month.

The U.S. Department of Health and Human Services (HHS) should identify and implement ways to formally coordinate activities relating to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Roundup: 5th Circuit Appeals in Louisiana, 4th Circuit Appeal in West Virginia

April 17, 2025 Shannon Young and Bella Czajkowski, Associate Editor/Senior Writer Views

Key briefs were filed recently in state contract pharmacy litigation in West Virginia and Louisiana.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HHS Briefs House E&C Committee Staff on Restructuring, Senate HELP Postpones Kennedy Hearing

April 15, 2025 Shannon Young, Associate Editor/Senior Writer Views

HHS Secretary Robert F. Kennedy Jr. was tentatively set to testify before the Senate HELP panel April 10 on his department's restructuring, a hearing which was ultimately postponed.

U.S. Department of Health and Human Services (HHS) officials last week briefed the Republican and Democratic staff of a key [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live